Vaxx to the Future

Season 1 Episode 90 TIP News for Dec. 8, 2021

December 08, 2021 The Immunization Partnership Season 1 Episode 90
Vaxx to the Future
Season 1 Episode 90 TIP News for Dec. 8, 2021
Show Notes Transcript

In today’s TIP News: Omicron arrives in Texas; Pfizer says we may need three doses of COVID vaccine to fight Omicron; a federal judge stops Biden vaccine mandate for federal contractors; and a 4-year study shows the HPV vaccine works. 


Hello, and welcome to TIP News for Dec. 8, 2021. TIP News is a podcast production of The Immunization Partnership. My name is John David Powell. 

In today’s TIP News: Omicron arrives in Texas; Pfizer says we may need three doses of COVID vaccine to fight Omicron; a federal judge stops Biden vaccine mandate for federal contractors; and a 4-year study shows the HPV vaccine works. 

We begin today with news that winter is coming to Texas, but the Omicron variant is already here. The Texas Department of State Health Services reports the coronavirus variant in a northwest Harris County woman in her 40s. Harris County public health officials say the woman is fully vaccinated and experienced some of the common COVID symptoms, but did not require hospitalization.  

The woman had not traveled beyond Texas recently, which suggests to public health officials that she caught the virus in her northwest Harris County community. 

Meantime, Houston public health officials said this week that the Omicron variant turned up in several Houston wastewater treatment plants in samples taken after Thanksgiving.  

Pfizer says its preliminary lab studies show two doses of the Pfizer-BioNTech COVID vaccine may not be enough to protect against Omicron, but three doses should neutralize the variant. That from a statement released by Pfizer chairman and CEO Albert Bourla. 

Another federal judge says stop to the Biden administration vaccine mandates. This time US District Court Judge R. Stan Baker of the Southern District of Georgia ruled the president overstepped his authority by requiring COVID shots for employees of federal contractors. In his ruling, the judge said the seven states that challenged the mandate set to take effect Jan. 4 are likely to win their lawsuits against the order. 

The Hill reports the Senate could vote today to nullify the administration mandate for large employers, which would give Republicans a big symbolic victory. 

Democratic senators Joe Manchin of West Virginia and Jon Tester of Montana expected to join the 50 Republicans to pass the resolution.  

No surprise about Tester who says he is not a fan of vaccine mandates for private employers, even though he supports mandates for healthcare workers and members of the armed services. 

Indiana’s Republican governor Eric Holcomb is frustrated at what he calls the absurd reasons folks give for not getting vaccinated. The Associated Press reports a woman told Holcomb that she was glad he opposed the federal vaccine mandates for large businesses, adding, however, that she was disappointed he was vaccinated against COVID because now he has a chip in him. 

Indiana’s neighbor to the north, Michigan, this week set another record for confirmed COVID hospitalizations: 4,404 for those keeping score at home. Forty of those patients were children, according to Michigan Medicine, which provides hospitalization data to the state health department. 

And this led a critical care doctor to call on the state and federal governments to send in all resources available and for healthcare workers who have left medicine to return to the field to help hospitals ride out this surge. 

Dr. Paul Bozyk is section head for pulmonary and medical care medicine at Beaumont Hospital in Royal Oak, Michigan, and vice chair of the Michigan State Medical Society board. He told the Detroit Free Press that health care in Michigan is stretched incredibly thin. 

And finally today, England’s National Health Service rolled out the first human papillomavirus vaccinations across the country thirteen years ago. That’s the HPV vaccine, which was supposed to protect students between 12 and 13 from cervical and other cancers. And it appears to be working. 

Cancer Research UK funded the study and published the results in The Lancet. Data show that by June 2019, the HPV vaccine seems may have resulted in 450 fewer cases of cervical cancer and 17,200 fewer cases of pre-cancerous cells.  

Researchers found a 97-percent drop in the number of students experiencing pre-cancerous cell changes if they’d received the vaccine at the age of 12 or 13, who would be in their twenties today. There also was an 87 percent drop in the rates of cervical cancer among those who got the HPV vaccine. The drop was 75 percent for those immunized between 14 and 16, and 39 percent for those immunized between 16 and 18.  

Michelle Mitchell, Cancer Research UK chief executive, told Forbes that results like these show the power of science. 

Indeed. 

That’s our TIP News for today, Dec. 8, 2021. 

TIP News is a podcast production of The Immunization Partnership. We invite you to subscribe to our podcasts, Vaxx Voice, which deals with vaccines in general, and Vaxx to the Future, where we feature information specifically related to COVID-19 and its vaccines. You can follow us on Twitter, Facebook, LinkedIn, Instagram, and YouTube. You can also find more information on our webpage, immunizeusa.org. For all of us at The Immunization Partnership, I’m John David Powell. Thanks for listening.